Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 19Ovarian Neoplasms 7Leiomyosarcoma 6Liposarcoma 4Liposarcoma, Myxoid 3Sarcoma, Ewing 2Osteosarcoma 2Solitary Fibrous Tumors 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyosarcoma Uterus 1Ichthyosis, X-Linked 1Histiocytoma, Malignant Fibrous 1Hemangioendothelioma 1Fanconi Anemia, Complementation Group D1 1Chondrosarcoma 1Carcinosarcoma 1Cancers With DNA Repair-Deficiency 1Bone Neoplasms 1

Interventions

Cyclophosphamide 16Temozolomide 13Vincristine 10Irinotecan 8Melphalan 7Doxorubicin 7Topotecan 6Granulocyte Colony-Stimulating Factor 6Busulfan 6fludarabine 5cabozantinib 5Etoposide 5Drug Therapy 5liposomal doxorubicin 4Sirolimus 4Ifosfamide 4Filgrastim 4regorafenib 3pegfilgrastim 3irinotecan sucrosofate 3fludarabine phosphate 3Zoledronic Acid 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Cisplatin 3Bone Marrow Transplantation 3Albumin-Bound Paclitaxel 3pegylated granulocyte colony-stimulating factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Ewing × Trabectedin × Clear all
NCT04067115 2025-12-17

U01CA236220

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed
37 enrolled
Sarcoma

Sarcoma, Ewing

NCT05131386 2023-03-27

SYNERGIAS

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown
85 enrolled
Sarcoma

Bone Neoplasms, Chondrosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡